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Abstract 
This thesis encompasses work that aimed to further understand genomic reprogramming, an 
event crucial in obtaining development in cloned embryos produced by somatic cell nuclear 
transfer (SCNT). An increasing number of different mammalian species have been cloned using 
nuclear transfer technology since Dolly the cloned sheep was first successfully produced. 
However, the biological mechanisms involved in the process of nuclear reprogramming are yet to 
be fully described. At the centre of this study was an intergeneric SCNT model, which was 
implemented to determine whether reprogramming factors are conserved across genera. The 
interaction between donor nucleus and recipient ooplasm was characterised with regard to 
developmental potential, timing of genome activation, nucleolus formation, and expression of 
significant proteins. 
In initial studies, fusion parameters of the intergeneric SCNT procedure were optimised for the 
ovine cytoplast and porcine donor granulosa cell. Cell fusion and lysis percentages were 
determined over a range of electrical pulse voltage, duration and repetition. The optimal 
electrofusion settings were a single DC pulse of 1.5 kV/cm for 20 Ilsec following a 2 sec 400 kHz 
alignment pulse. In addition, it was demonstrated that ovine oocytes were sensitive to electric 
stimulation to the extreme that oocyte activation would occur no matter how low the voltage. The 
practical significance was that it would not be possible to implement a fusion before activation 
protocol. 
The ability of the ooplasm of one species to replicate chromosomes and support early embryo 
cleavage was determined in a preliminary experiment where intergeneric embryos were produced 
by SCNT using bovine and ovine foetal fibroblasts, and ovine ooplasm. After their construction, 
the embryos were allowed to develop for 7 days in vitro and the developmental stage determined 
by Hoechst staining and nuclei counting. In addition, chromosome spreads of the ovine and 
bovine somatic foetal fibroblast cell lines used in SCNT, as well as the intra- and intergeneric 
SCNT embryos were prepared to determine whether the ovine ooplasm was replicating the 
chromosomes according to the karyotype of the donor nucleus. The somatic cells were 
karyotyped with 54 and 60 chromosomes counted for ovine and bovine cells respectively. 
Bovine-ovine embryos were characterised as having a bovine karyotype as distinct from an ovine 
karyotype, due to the presence of only two metacentric chromosomes as compared with six that 
are found in the latter. These preliminary results indicated that bovine nuclei obtained from foetal 
fibroblast cells could initiate early pre-implantation embryo development with the support of 
ovine oocyte cytoplasm. The development of a proportion (33%) of ovine-ovine intrageneric 
SCNT embryos beyond the 16-cell stage indicated that an extensive characterisation of an 
intergeneric model could be performed satisfactorily. 
I t  was hypothesised that the ovine ooplasm would possess the ability to direct in vitro 
preimplantation embryo development after nuclear transfer using donor nuclei from a different 
genus, as has been demonstrated in studies using bovine and rabbit ooplasm. In this study, 
intergeneric SCNT embryos were constructed by the separate fusion of porcine and bovine cells 
with ovine cytoplasts (bovine-ovine and porcine-ovine respectively), cultured in vitro and the 
developmental characteristics compared with ovine-ovine SeNT embryos as well as ovine in 
vitro produced (IVP) embryos. These four groups of embryos were sampled to determine embryo 
cell numbers at 24, 36, 48, 72, 96, 120 and 168 h post-activation to compare development over 
time. Despite cleaving normally and undergoing the first three cleavage divisions at a rate 
comparable with ovine-ovine SCNT embryos, a major block in development occurred in the 
intergeneric embryos at the 8-16 cell stage. Consequently, no blastocyst formation was obtained 
as observed for the IVP and ovine-ovine SCNT controls. These results indicate that unlike the 
rabbit and bovine ooplasm, the ovine ooplasm is not suitable for intergeneric reprogramming of 
somatic nuclei from another genus, at least of porcine or bovine origin. 
To determine the effect of a less differentiated donor nucleus on intergeneric developmental 
potential, embryonic cell nuclear transfer (ECNT) was conducted in a separate experiment by 
fusing pluripotent bovine and ovine donor cells (obtained from day-4 preimplantation embryos) 
to ovine cytoplasts. After 7 days of culture, the cell number of embryos was determined by 
Hoechst staining and fluorescent observation. Despite observing a single bovine-ovine blastocyst 
(4.8%), the developmental block remained at the 8-16 cell stage of development. This outcome 
indicates that a less differentiated nucleus does not increase intergeneric developmental 
capability. 
It is well documented that the ooplasm supplies a large amount of mRNA and protein to the 
newly formed embryo, crucial for normal development leading up to the major activation of the 
embryonic genome. However, the interaction between the ooplasm as compared with the donor 
nucleus in SCNT embryos during this developmental period is poorly understood. This 
intergeneric SCNT model provided an opportunity to determine the role of the ooplasm on 
nucleolus formation, which is a marker for genome activation. Ultrastructural evidence was 
obtained that indicates the ovine ooplasm directs the initial assembly of the nucleolus 
independent of the species of the nuclear donor. Intergeneric porcine-ovine SCNT and 
intrageneric ovine-ovine SCNT embryos were constructed and the nucleolus ultrastructure and 
nucleolus associated rRNA synthesis examined in 1-,2-,4-, early 8-, late 8- and 16-cell embryos 
using transmission electron microscopy (TEM) and light microscopical autoradiography. 
Intergeneric porcine-ovine SCNT embryos exhibited nucleolar precursor bodies (NPBs) of an 
ovine (ruminant) ultrastructure, but no active rRNA producing fibrillogranular nucleoli at any of 
the stages. Unusually, cytoplasmic organelles were located inside the nucleus of two porcine­
ovine SCNT embryos. The ovine-ovine SCNT embryos, on the other hand, revealed 
fibrillogranular nucleoli in 16-cell embryos. In parallel, autoradiographic labelling over the 
nucleoplasm and, in particular, the nulcleoli was detected. Bovine-ovine SCNT embryos at the 8-
cell stage were examined for nucleolar morphology and exhibited ruminant-type NPBs as well as 
structures that appeared to comprise of broken down fibrillar material, perhaps formerly of 
nucleolar origin from the donor cell. These observations indicate that factors within the ovine 
ooplasm are playing a role in the initial assembly of the embryonic nucleolus in intrageneric 
seNT embryos. 
To further characterise nucleolus formation, immunocytochemical localisation by confocal 
microscopy of nucleolin, fibrillarin and RNA polymerase, three key proteins involved in 
processing rRNA transcripts, was performed on early 8-, late 8- and 16-cell embryos for ovine­
ovine and porcine-ovine seNT embryos. Nucleolin was localised throughout the nucleoplasm for 
all developmental stages examined in porcine-ovine and ovine-ovine seNT embryos and, in 
particular, intensity around the presumptive nucleolar compartments in the later developmental 
stages. Fibrillarin and RNA polymerase I, on the other hand, were not detected in any ovine­
ovine or porcine-ovine seNT embryos or ovine IVP controls, although both proteins were 
detected in control bovine IVP blastocysts. This result indicates that the antifibrillarin and anti­
RNA polymerase I were not compatible with the ovine form of these respective proteins. As 
nucleolin is not present in porcine in vivo embryos before the major activation of the embryonic 
genome, its presence in porcine-ovine SeNT embryo nucleus indicates that nucleolin is derived 
from the abundant protein and mRNA stored in the ovine ooplasm. 
The intergeneric seNT model established in this thesis demonstrates that the ovine ooplasm 
lacks the ability to support embryonic development beyond the 16-cell stage. The TEM and 
autoradiographical studies, in combination with the protein immunocytochemistry study, 
confirmed that these embryos are unable to undergo the major activation of the embryonic 
genome, and that the ooplasm influences the initial nucleolar assembly in these embryos. 
